Clin2
NCT07266571Worth exploringNot yet recruiting

Pycnogenol for Gulf War Illness in veterans

Gulf War Syndrome

Part of Injuries & trauma clinical trials.

This study tests whether a natural supplement called Pycnogenol (from French maritime pine bark) can help with symptoms of Gulf War Illness. It lasts 12 months and is for male veterans who have already been in a related study.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be a male veteran with Gulf War Illness (diagnosed using both Kansas and CDC definitions).
  • You need to be able to take part in a 12-month study.
  • You cannot be in another experimental treatment study right now.
  • You must not have a blood clotting disorder.
  • You cannot have diabetes with an A1C over 9.
  • You cannot take certain medications like blood thinners, lithium, tacrolimus, cancer drugs, or nitroglycerin.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07151248Recruiting
Earlobe stimulation for Gulf War veterans with chronic pain

This trial tests a mild electrical stimulation device (called CES) on the earlobe to see if it can reduce pain and improve brain function in veterans with Gulf War Illness. You will have brain scans and answer questions about your symptoms.

Atlanta, Georgia
NCT06515184Recruiting· Phase 3
Coenzyme Q10 for Gulf War illness study

This study tests whether coenzyme Q10 (a natural supplement) can improve symptoms of Gulf War illness, such as fatigue and body pain. It involves taking the supplement or placebo for several months, with regular check-ins via Zoom and a few blood draws at a local lab.

La Jolla, California
NCT05992311Recruiting· Phase 1
Testing montelukast for gulf war illness

This study tests whether montelukast, a medication for asthma and allergies, can help improve thinking problems in veterans with Gulf War Illness. The trial involves taking the study drug or a placebo for 8 weeks, with weekly phone check-ins.

Houston, Texas
NCT05675878Recruiting· Phase 3
Testing a specific diet for Gulf War illness

This Phase 3 study tests whether following a study diet can improve symptoms of Gulf War illness. It may help people by confirming whether diet changes are an effective treatment.

Washington D.C., District of Columbia
NCT04987775Recruiting· Early Phase 1
Study of NAC for Gulf War illness in veterans

This early-stage study tests the treatment called NAC to understand how it may work in veterans with Gulf War illness–related symptoms like fatigue and brain/mood changes. It also looks at “mechanisms,” meaning what’s happening in the body and brain while you’re in the study.

Palo Alto, California
NCT05736146Recruiting
Testing Gulf War illness blood markers for better diagnosis

This study checks blood tests to see whether they can help confirm Gulf War illness. If you qualify as having Gulf War illness (or are a similar Gulf War veteran without it), your blood and health information may be used to validate these marker tests.

Palo Alto, California

Hear when a new Gulf War Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.